Related Experiment Video

Updated: Apr 5, 2026

Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development
05:44

Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development

Published on: May 17, 2024

1.3K

THE ASSOCIATION BETWEEN PRE-PREGNANCY OBESITY AND WEIGHT GAIN IN PREGNANCY, WITH GROWTH DEVIATIONS IN NEWBORNS

Dennis Camacho-Buenrostro1, J Jesús Pérez-Molina2, Edgar M Vásquez-Garibay3

  • 1Instituto de Nutrición Humana, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, (Jalisco).. jesusperezmolina@gmail.com.

Nutricion Hospitalaria
|August 12, 2015
PubMed

Insights

Maternal pre-pregnancy obesity and excessive weight gain during pregnancy are significant predictors of newborns being large for gestational age (LGA). This study highlights risks for infants born to mothers with obesity, emphasizing the need for monitoring. Keywords: maternal obesity, pregnancy weight gain, large for gestational age.

Area of Science:

  • Obstetrics and Gynecology
  • Perinatal Medicine
  • Maternal-Fetal Health

Background:

  • Pregnancy obesity is linked to increased maternal and fetal morbidity.
  • Understanding the impact of maternal pre-pregnancy weight on infant growth is crucial for perinatal care.

Purpose of the Study:

  • To quantify the association between pre-pregnancy obesity and infant growth deviations.
  • To identify predictors of large for gestational age (LGA) and small for gestational age (SGA) newborns.

Main Methods:

  • A case-control study was conducted involving 280 mother-child dyads.
  • Logistic regression analysis assessed the relationship between pre-pregnancy obesity and infant size (LGA/SGA).
  • Gynecoobstetric and socioeconomic data were collected and analyzed.

Main Results:

  • Pre-pregnancy obesity was significantly associated with growth deviations (OR 2.65).
  • Elevated weight gain during pregnancy (OR 1.98) and maternal disease (OR 2.62) were also linked to deviations.
  • Multivariate analysis confirmed pre-pregnancy obesity and high gestational weight gain as predictors of LGA.

Conclusions:

  • Pre-pregnancy obesity and excessive gestational weight gain are key predictors of LGA in newborns.
  • Findings are particularly relevant for young women with limited economic resources.
  • These factors underscore the importance of weight management during pregnancy.
Abstract

More Related Videos

Assessment of Child Anthropometry in a Large Epidemiologic Study09:36

Assessment of Child Anthropometry in a Large Epidemiologic Study

Published on: February 2, 2017

28.1K
A Primary Human Trophoblast Model to Study the Effect of Inflammation Associated with Maternal Obesity on Regulation of Autophagy in the Placenta11:44

A Primary Human Trophoblast Model to Study the Effect of Inflammation Associated with Maternal Obesity on Regulation of Autophagy in the Placenta

Published on: September 27, 2017

11.9K

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.5K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.6K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
343
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
394
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.5K